Author response for "Development of a CXCR4 antagonistic peptide P12 to suppress pancreatic cancer progress via enhancing T cell responses and sensitizing cells to gemcitabine"Xin Huang, Haiyan Xu, Hang Wu et al.|Unknown|2025Cited by 0
Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress <i>via</i> enhancing T cell responses and sensitizing cells to gemcitabineXin Huang, Xuanxin Liu, Dapeng Li et al.|RSC Medicinal Chemistry|2025Cited by 0